Joint Formulary & PAD

Bimatoprost with timolol - Glaucoma / ocular hypertension

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Eye drops
  • Eye drops (preservative free
  • unit dose)
Associated Icons :
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Bimatoprost with timolol
Indication :
Glaucoma / ocular hypertension
Group Name :
Keywords :
Intra-ocular pressure
Brand Names Include :
Ganfort, Visublend, Eyzeetan, Bimiduo
Important Information :

Prescribe generically. Initiation by specialist team before transfer of prescribing to primary care

Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
0

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Bimatoprost with timolol is used to treat.

  • No records returned.